Multi-Center Phase 2 Study of Pembroluzimab (Pembro) and Azacitidine ( AZA) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) and in Newly Diagnosed (>= 65 Years) AML Patients Meeting Abstract

cited authors

  • Gojo, Ivana; Stuart, Robert K.; Webster, Jonathan; Blackford, Amanda; Varela, Juan Carlos; Morrow, Jillian; DeZern, Amy E.; Foster, Matthew C.; Levis, Mark J.; Coombs, Catherine C.; Prince, Gabrielle T.; Smith, B. Douglas; Van Deventer, Hendrik W.; Jamieson, Katarzyna; Varadhan, Ravi; Vincent, Benjamin G.; Serody, Jonathan S.; Luznik, Leo; Zeidner, Joshua F.

authors

Publication Date

  • November 13, 2019

webpage

published in

category

volume

  • 134